Results 171 to 180 of about 31,892 (198)
Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms. [PDF]
Shyamsunder S, Lu Z, Takiar V, Waltz SE.
europepmc +1 more source
Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation. [PDF]
Phongphithakchai A+7 more
europepmc +1 more source
Differential Role of CD318 in Tumor Immunity Affecting Prognosis in Colorectal Cancer Compared to Other Adenocarcinomas. [PDF]
Patel B, Curcic M, Eltokhy MA, Prasad S.
europepmc +1 more source
Previously, we have reported a new biomolecular phenomenon spanning between protein folding and binding, termed as self-binding peptides (SBPs), where a short peptide segment in monomeric protein functions as a molecular switch by dynamically binding to/unbinding from its cognate domain in the monomer (Yang et al. J. Chem. Inf.2015, 55, 329-342). Here,
Zhengya Bai+4 more
openaire +4 more sources
ABSTRACTThe epithelial-to-mesenchymal transition is the first step required for breast cancer to initiate metastasis. The aberrant activation of proto-oncogene tyrosine-protein kinase Src regulates multiple functions during tumor progression. Cardiotoxin III, a basic polypeptide isolated from Naja naja atra venom, has been shown to exhibit anticancer ...
Long-Sen Chang+4 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Trends in kinase drug discovery: targets, indications and inhibitor design
Nature Reviews Drug Discovery, 2021Helgi B Schiöth+2 more
exaly
Kinase drug discovery 20 years after imatinib: progress and future directions
Nature Reviews Drug Discovery, 2021Darren Cross+2 more
exaly
Kinase inhibition in autoimmunity and inflammation
Nature Reviews Drug Discovery, 2021Ali A Zarrin+2 more
exaly